Editorial Material
Oncology
Prathyusha Konda, Liubov M. Lifshits, John A. Roque, Houston D. Cole, Colin G. Cameron, Sherri A. McFarland, Shashi Gujar
Summary: A new class of ruthenium-based photosensitizers have been discovered to induce potent cytotoxicity and immunogenic cell death in melanoma cells when activated by NIR light, potentially establishing protective antitumor immunity.
Article
Medicine, Research & Experimental
Naihan Huang, Along Qian, Yiming Zou, Miaoli Lin, Weilun Pan, Ming Chen, Wei Meng, Wenhua Zhang, Jinxiang Chen
Summary: Research aims to improve the immune response of radiation therapy (RT) by reshaping the immunosuppressive tumor microenvironment. A nanocomposite called UMP, constructed with core-shell UiO@Mn3O4, is used to reshape the TME and enhance immunogenic RT, inducing strong immunogenic cell death. This study is significant for TME reshaping and the development of cancer nanomedicine.
Article
Engineering, Biomedical
Qing Xie, Zhen Li, Yang Liu, Dawei Zhang, Meng Su, Hiroaki Niitsu, Yuanyuan Lu, Robert J. Coffey, Mingfeng Bai
Summary: This study demonstrates the potential of TSPO-PDT as a successful therapeutic for CRC, with direct tumor growth suppression and the provocation of host anti-tumor immunity. The abscopal effect was observed in untreated tumors, highlighting the systemic effects of TSPO-PDT.
ACTA BIOMATERIALIA
(2021)
Review
Chemistry, Multidisciplinary
Shiliang He, Xiao Jia, Sai Feng, Junqing Hu
Summary: This review examines the effectiveness of three strategies for developing advanced phototherapeutics based on various tumor microenvironment characteristics. The first strategy involves targeted delivery of phototherapeutics to tumors with the assistance of tumor microenvironment-induced nanoparticle disassembly or surface modification. The second strategy involves near-infrared absorption increase-induced phototherapy activation triggered by tumor microenvironment factors. The third strategy involves enhancing therapeutic efficacy by ameliorating the tumor microenvironment.
Article
Chemistry, Multidisciplinary
Naihan Huang, Xiao-Yan Tang, Wei Meng, Ye-Hua Lai, Xuan Zhou, Xue-Zhao Yu, Wen-Hua Zhang, Jin-Xiang Chen
Summary: By integrating MnS-reprogrammed tumor microenvironment with Hf-based UiO-sensitized radiation therapy, a core-shell nanosensitizer UiO@MnS (UM) was constructed to enhance the efficacy of radiation therapy and induce immune response.
Review
Chemistry, Multidisciplinary
Xinghang Dai, Long Ren, Mengxi Liu, Hao Cai, Hu Zhang, Qiyong Gong, Zhongwei Gu, Kui Luo
Summary: MDSCs have been explored as an important immunotherapeutic target in cancer immunology, and nanomedicines have shown potential in reversing immunosuppressive tumors into immunoresponsive ones to enhance therapeutic efficacy.
Article
Materials Science, Multidisciplinary
Shi-Man Zhang, Xiao-Kang Jin, Guo-Feng Luo, Jun-Long Liang, Yu-Zhang Wang, Jia-Wei Wang, Ran Meng, Yan-Tong Lin, Wei-Hai Chen, Xian-Zheng Zhang
Summary: In this study, a bacteria-based lactate bioconsumer was developed to efficiently metabolize lactate in tumors and activate immune responses for tumor suppression. The bioconsumer could reshape the immunosuppressive tumor microenvironment and enhance antitumor immunity.
ACS MATERIALS LETTERS
(2023)
Article
Engineering, Biomedical
Jia Wan, Xianghong Zhang, Zhihong Li, Fuhao Mo, Dongsheng Tang, Haihua Xiao, Jingcheng Wang, Guanghua Rong, Tang Liu
Summary: ROS-responsive nanoparticles with mitochondrial targeting performance were designed to induce immunogenic cell death and trigger antitumor immune responses. By enhancing ROS damage and disrupting mitochondrial redox homeostasis, the nanoparticles promote cancer cell apoptosis and antitumor immune response, thus achieving cancer immunotherapy.
ADVANCED HEALTHCARE MATERIALS
(2023)
Review
Pharmacology & Pharmacy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, Huile Gao
Summary: Cancer immunotherapy has flourished and revolutionized tumor therapies, but challenges such as low patient response rates and immune-related side effects remain. The immunosuppressive tumor microenvironment (TME) plays a pivotal role in tumor progression and metastasis, but also provides targets for remodeling the TME. Remodeling the TME and strengthening patients' immune systems can improve the effectiveness of immunotherapy.
ACTA PHARMACEUTICA SINICA B
(2022)
Article
Multidisciplinary Sciences
Alba Rodriguez-Garcia, Rachel C. Lynn, Mathilde Poussin, Monika A. Eiva, Lauren C. Shaw, Roddy S. O'Connor, Nicholas G. Minutolo, Victoria Casado-Medrano, Gonzalo Lopez, Takami Matsuyama, Daniel J. Powell
Summary: The study demonstrates that targeting FR beta-expressing TAMs with CAR-T cells can enhance antitumor immune responses and improve the efficacy of adoptive T-cell therapy in pre-clinical models.
NATURE COMMUNICATIONS
(2021)
Review
Medicine, Research & Experimental
Min Zhang, Yifan Zhao, He Ma, Yusong Sun, Jie Cao
Summary: Photodynamic therapy (PDT) is a promising method for tumor treatment by inducing immunogenic cell death and local inflammation. However, additional strategies are needed to enhance the immune response against cancer cells.
Article
Engineering, Biomedical
Shuang Zeng, Chen Chen, Liuwei Zhang, Xiaosheng Liu, Ming Qian, Hongyan Cui, Jingyun Wang, Qixian Chen, Xiaojun Peng
Summary: By targeting specific subcellular organelles and utilizing photosensitizers, we have successfully activated pyroptosis and immunogenic cell death, which effectively inhibits tumor growth and metastasis. In vivo experiments have demonstrated that this approach not only suppresses the growth of primary tumors but also has an abscopal effect on distant tumors and metastatic tumors.
BIOACTIVE MATERIALS
(2023)
Article
Chemistry, Multidisciplinary
Xue Lou, Hui Wang, Yu Liu, Yongwei Huang, Zhonghua Liu, Wei Zhang, Tie Wang
Summary: This study presents a perylene monoamide-based reactive oxygen species supergenerator that induces oxidative stress and triggers immunogenic cell death, leading to efficient tumor therapy. It also demonstrates the potential of perylene as a therapeutic platform for immunogenic photochemotherapy against hypoxic tumors.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
(2023)
Review
Pharmacology & Pharmacy
Jiwoong Choi, In-Cheol Sun, Hee Sook Hwang, Hong Yeol Yoon, Kwangmeyung Kim
Summary: Photodynamic nanomedicines have improved the therapeutic efficacy of photosensitizers by overcoming their limitations. Functional photodynamic nanomedicines can overcome the oxygen depletion and tissue light penetration limitations of photodynamic therapy. Recent studies have shown that combining photodynamic nanomedicines with chemotherapy or immune checkpoint inhibitor therapy can treat metastatic tumors systemically by inducing antitumor immune responses.
ADVANCED DRUG DELIVERY REVIEWS
(2022)
Review
Immunology
Sophie Janssens, Sofie Rennen, Patrizia Agostinis
Summary: Dendritic cells play a crucial role in the cancer immunity cycle by interacting with malignant cells undergoing immunogenic cell death, leading to DC maturation and activation of antitumor immunity. This process relies on the perception and decoding of danger signals released during immunogenic cell death.
IMMUNOLOGICAL REVIEWS
(2023)